文献速递免疫规划传染病防控与疫情报告慢病防控与筛查

HIV感染者接种四剂三倍剂量与四剂标准剂量乙型肝炎疫苗后免疫原性持续时间:中国一年随访研究

Duration of immunogenicity of four triple doses and four standard doses hepatitis B vaccine in adults infected with human immunodeficiency virus: A one-year follow-up study in China.
PubMed 文献 · Vaccine · 2025-08-11

在HIV成人感染者中开展开放标签平行组随机对照试验,比较3剂或4剂20 μg或60 μg乙型肝炎疫苗的免疫原性持续时间。随访至18个月时,IM20×3组、IM20×4组和IM60×4组的抗-HBs几何平均浓度和应答率分别为200.40 mIU/ml与66.67%(58/87)、382.20 mIU/ml与75.58%(65/86)、628.50 mIU/ml与83.13%(69/83)。结论认为四剂三倍剂量方案改善了男性患者的免疫原性持续时间。

要点

  • 18个月时IM60×4组抗-HBs应答率83.13%(69/83),IM20×3组为66.67%(58/87)。
  • IM60×4组与IM20×3组抗-HBs应答率差异有统计学意义(P < 0.017)。
  • 多因素分析显示性别和疫苗接种方案影响18个月时免疫原性持续时间。

核心结论

  • 在HIV成人感染者一年随访(18个月)中,四剂三倍剂量乙型肝炎疫苗方案改善了男性患者的免疫原性持续时间。

研究设计与样本

  • 开放标签、平行组、随机对照试验,于2020年5月至2021年在运城市第二医院开展,随访延长至2022年以评估免疫原性持续时间。

主要发现

  • 18个月时IM20×3组抗-HBs几何平均浓度为200.40 mIU/ml、应答率为66.67%(58/87),IM20×4组为382.20 mIU/ml、75.58%(65/86),IM60×4组为628.50 mIU/ml、83.13%(69/83)。
  • IM20×3组与IM60×4组之间差异有统计学意义(P < 0.017)。
  • 多因素分析中,性别和疫苗接种方案影响18个月时免疫原性持续时间。
  • 在校正混杂因素后,乘法尺度上男性与IM60×4组之间的交互效应有统计学意义。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: People infected with human immunodeficiency virus (HIV) are more likely to be infected with hepatitis B virus (HBV), which is a significant public health concern. It is essential to provide protection through the hepatitis B vaccine and to stimulate higher and more sustained levels of anti-HBs antibodies to ensure long-term immunity. We aimed to enhance the duration of immunogenicity by implementing high-dose and multiple-schedule hepatitis B vaccination in adults infected with HIV. METHODS: This open-label, parallel-group, randomised controlled trial (RCT) was conducted between May 2020 and January 2021 at the Second Hospital of Yuncheng. Patients were randomised to receive 3 or 4 doses of 20 μg or 60 μg of hepatitis B vaccine. The follow-up period was extended to 2022 to evaluate the duration of immunogenicity. RESULTS: The geometric mean concentration (GMC) and response rates of hepatitis B surface antibody (anti-HBs) at month 18 were 200.40 mIU/ml and 66.67 % (58/87) in the IM20 × 3 group, 382.20 mIU/ml and 75.58 % (65/86) in the IM20 × 4 group, 628.50 mIU/ml and 83.13 % (69/83) in the IM60 × 4 group, which were significantly different between the IM20 × 3 and IM60 × 4 groups (P < 0.017). In multivariate analysis, gender and vaccination regimens affected the duration of immunogenicity at month 18. Regarding the multiplicative scale, the interaction effect was significant between the male and the IM60 × 4 group after adjusting for confounders. CONCLUSION: In the one-year follow-up (month 18) of adults infected with HIV, four triple doses regimen of hepatitis B vaccine improved the duration of immunogenicity in male patients.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Gao L, Zhang X, Mo X, et al. Duration of immunogenicity of four triple doses and four standard doses hepatitis B vaccine in adults infected with human immunodeficiency virus: A one-year follow-up study in China. Vaccine. 2025. PMID: 40795702. doi:10.1016/j.vaccine.2025.127596

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。